ALB and chronic kidney disease: We previously performed a retrospective observational survey of 624 T2DM patients with chronic kidney disease (CKD) and demonstrated that SGLT-2i treatment decreased the urine albumin-to-creatinine ratio (ACR) in clinical practice20.